FDAnews
www.fdanews.com/articles/156973-roxane-says-shared-rems-can-work-dismissing-prometheus-cp-concerns

Roxane Says Shared REMS Can Work, Dismissing Prometheus’ CP Concerns

July 11, 2013
While each risk evaluation and mitigation strategy (REMS) presents its own set of challenges, it doesn’t preclude the successful establishment of shared systems, a representative of Roxane Laboratories said Wednesday in the generic drugmaker’s first public comments on the subject.
Drug Industry Daily